- Home
- TR vs PTGX Comparison
TR vs PTGX Comparison
Compare TR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- PTGX
- Stock Information
- Founded
- TR 1896
- PTGX 2006
- Country
- TR United States
- PTGX United States
- Employees
- TR N/A
- PTGX N/A
- Industry
- TR Specialty Foods
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- TR Consumer Staples
- PTGX Health Care
- Exchange
- TR Nasdaq
- PTGX Nasdaq
- Market Cap
- TR 2.2B
- PTGX 2.3B
- IPO Year
- TR N/A
- PTGX 2016
- Fundamental
- Price
- TR $32.34
- PTGX $38.75
- Analyst Decision
- TR
- PTGX Strong Buy
- Analyst Count
- TR 0
- PTGX 8
- Target Price
- TR N/A
- PTGX $57.13
- AVG Volume (30 Days)
- TR 100.8K
- PTGX 509.7K
- Earning Date
- TR 03-03-2025
- PTGX 02-21-2025
- Dividend Yield
- TR 0.56%
- PTGX N/A
- EPS Growth
- TR 7.80
- PTGX N/A
- EPS
- TR 1.31
- PTGX 4.23
- Revenue
- TR $727,121,000.00
- PTGX $434,433,000.00
- Revenue This Year
- TR N/A
- PTGX $445.33
- Revenue Next Year
- TR N/A
- PTGX N/A
- P/E Ratio
- TR $23.87
- PTGX $9.20
- Revenue Growth
- TR N/A
- PTGX 624.05
- 52 Week Low
- TR $27.58
- PTGX $24.22
- 52 Week High
- TR $34.00
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- TR 61.36
- PTGX 52.47
- Support Level
- TR $30.92
- PTGX $37.50
- Resistance Level
- TR $31.82
- PTGX $39.37
- Average True Range (ATR)
- TR 0.85
- PTGX 1.32
- MACD
- TR 0.14
- PTGX 0.16
- Stochastic Oscillator
- TR 93.82
- PTGX 67.70
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.